Investigation of a bicyclo[1.1.1]pentane as a phenyl replacement within an LpPLA2 inhibitor

Nicholas Measom, Kenneth D. Down, David J. Hirst, Craig Jamieson, Eric S. Manas, Vipulkumar K. Patel, Donald O. Somers

Research output: Contribution to journalArticle

22 Citations (Scopus)
41 Downloads (Pure)

Abstract

We describe the incorporation of a bicyclo[1.1.1]pentane moiety within two known LpPLA2 inhibitors to act as bioisosteric phenyl replacements. An efficient synthesis to the target compounds was enabled with a dichlorocarbene insertion into a bicyclo[1.1.0]butane system being the key transformation. Potency, physicochemical, and X-ray crystallographic data were obtained to compare the known inhibitors to their bioisosteric counterparts, which showed the isostere was well tolerated and positively impacted on the physicochemical profile.
Original languageEnglish
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume7
DOIs
Publication statusPublished - 15 Nov 2016

Fingerprint

X-Rays
X rays
dichlorocarbene
butane
pentane

Keywords

  • LpPLA2
  • bicyclo[1.1.1]pentane
  • bioisostere
  • darapladib
  • cardiovascular disease
  • physicochemical
  • bioisosteric phenyl replacements

Cite this

Measom, Nicholas ; Down, Kenneth D. ; Hirst, David J. ; Jamieson, Craig ; Manas, Eric S. ; Patel, Vipulkumar K. ; Somers, Donald O. / Investigation of a bicyclo[1.1.1]pentane as a phenyl replacement within an LpPLA2 inhibitor. In: ACS Medicinal Chemistry Letters . 2016 ; Vol. 7.
@article{5f9d4a408e164f4783612bcb44f7db1b,
title = "Investigation of a bicyclo[1.1.1]pentane as a phenyl replacement within an LpPLA2 inhibitor",
abstract = "We describe the incorporation of a bicyclo[1.1.1]pentane moiety within two known LpPLA2 inhibitors to act as bioisosteric phenyl replacements. An efficient synthesis to the target compounds was enabled with a dichlorocarbene insertion into a bicyclo[1.1.0]butane system being the key transformation. Potency, physicochemical, and X-ray crystallographic data were obtained to compare the known inhibitors to their bioisosteric counterparts, which showed the isostere was well tolerated and positively impacted on the physicochemical profile.",
keywords = "LpPLA2, bicyclo[1.1.1]pentane, bioisostere, darapladib, cardiovascular disease, physicochemical, bioisosteric phenyl replacements",
author = "Nicholas Measom and Down, {Kenneth D.} and Hirst, {David J.} and Craig Jamieson and Manas, {Eric S.} and Patel, {Vipulkumar K.} and Somers, {Donald O.}",
year = "2016",
month = "11",
day = "15",
doi = "10.1021/acsmedchemlett.6b00281",
language = "English",
volume = "7",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",

}

Investigation of a bicyclo[1.1.1]pentane as a phenyl replacement within an LpPLA2 inhibitor. / Measom, Nicholas; Down, Kenneth D.; Hirst, David J.; Jamieson, Craig; Manas, Eric S.; Patel, Vipulkumar K.; Somers, Donald O.

In: ACS Medicinal Chemistry Letters , Vol. 7, 15.11.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Investigation of a bicyclo[1.1.1]pentane as a phenyl replacement within an LpPLA2 inhibitor

AU - Measom, Nicholas

AU - Down, Kenneth D.

AU - Hirst, David J.

AU - Jamieson, Craig

AU - Manas, Eric S.

AU - Patel, Vipulkumar K.

AU - Somers, Donald O.

PY - 2016/11/15

Y1 - 2016/11/15

N2 - We describe the incorporation of a bicyclo[1.1.1]pentane moiety within two known LpPLA2 inhibitors to act as bioisosteric phenyl replacements. An efficient synthesis to the target compounds was enabled with a dichlorocarbene insertion into a bicyclo[1.1.0]butane system being the key transformation. Potency, physicochemical, and X-ray crystallographic data were obtained to compare the known inhibitors to their bioisosteric counterparts, which showed the isostere was well tolerated and positively impacted on the physicochemical profile.

AB - We describe the incorporation of a bicyclo[1.1.1]pentane moiety within two known LpPLA2 inhibitors to act as bioisosteric phenyl replacements. An efficient synthesis to the target compounds was enabled with a dichlorocarbene insertion into a bicyclo[1.1.0]butane system being the key transformation. Potency, physicochemical, and X-ray crystallographic data were obtained to compare the known inhibitors to their bioisosteric counterparts, which showed the isostere was well tolerated and positively impacted on the physicochemical profile.

KW - LpPLA2

KW - bicyclo[1.1.1]pentane

KW - bioisostere

KW - darapladib

KW - cardiovascular disease

KW - physicochemical

KW - bioisosteric phenyl replacements

UR - http://pubs.acs.org/journal/amclct

U2 - 10.1021/acsmedchemlett.6b00281

DO - 10.1021/acsmedchemlett.6b00281

M3 - Article

VL - 7

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

ER -